Ying Huang
Stock Analyst at B of A Securities
(2.66)
# 1,939
Out of 4,826 analysts
38
Total ratings
60.71%
Success rate
11.42%
Average return
Main Sectors:
Stocks Rated by Ying Huang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $555 → $567 | $503.77 | +12.55% | 12 | Mar 31, 2025 | |
| GILD Gilead Sciences | Maintains: Neutral | $70 → $72 | $102.91 | -30.04% | 8 | Feb 5, 2020 | |
| RDUS Radius Recycling | Maintains: Buy | $51 → $47 | $29.38 | +59.97% | 1 | Jul 25, 2018 | |
| RGNX REGENXBIO | Downgrades: Neutral | $64 → $80 | $10.10 | +692.08% | 3 | Jul 23, 2018 | |
| ESPR Esperion Therapeutics | Downgrades: Underperform | n/a | $1.08 | - | 2 | May 2, 2018 | |
| CTMX CytomX Therapeutics | Maintains: Buy | $34 → $40 | $0.90 | +4,344.44% | 2 | Mar 8, 2018 | |
| BLUE bluebird bio | Maintains: Neutral | $3,700 → $4,360 | $3.93 | +110,841.48% | 1 | Feb 22, 2018 | |
| PBYI Puma Biotechnology | Maintains: Buy | $135 → $115 | $3.13 | +3,574.12% | 2 | Jan 24, 2018 | |
| IRWD Ironwood Pharmaceuticals | Downgrades: Underperform | n/a | $0.94 | - | 4 | Jan 5, 2018 | |
| BIIB Biogen | Maintains: Buy | $358 → $365 | $122.48 | +198.01% | 1 | Oct 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $33 | $1.61 | +1,949.69% | 1 | Sep 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $278.45 | - | 1 | Feb 1, 2017 |
Vertex Pharmaceuticals
Mar 31, 2025
Maintains: Buy
Price Target: $555 → $567
Current: $503.77
Upside: +12.55%
Gilead Sciences
Feb 5, 2020
Maintains: Neutral
Price Target: $70 → $72
Current: $102.91
Upside: -30.04%
Radius Recycling
Jul 25, 2018
Maintains: Buy
Price Target: $51 → $47
Current: $29.38
Upside: +59.97%
REGENXBIO
Jul 23, 2018
Downgrades: Neutral
Price Target: $64 → $80
Current: $10.10
Upside: +692.08%
Esperion Therapeutics
May 2, 2018
Downgrades: Underperform
Price Target: n/a
Current: $1.08
Upside: -
CytomX Therapeutics
Mar 8, 2018
Maintains: Buy
Price Target: $34 → $40
Current: $0.90
Upside: +4,344.44%
bluebird bio
Feb 22, 2018
Maintains: Neutral
Price Target: $3,700 → $4,360
Current: $3.93
Upside: +110,841.48%
Puma Biotechnology
Jan 24, 2018
Maintains: Buy
Price Target: $135 → $115
Current: $3.13
Upside: +3,574.12%
Ironwood Pharmaceuticals
Jan 5, 2018
Downgrades: Underperform
Price Target: n/a
Current: $0.94
Upside: -
Biogen
Oct 18, 2017
Maintains: Buy
Price Target: $358 → $365
Current: $122.48
Upside: +198.01%
Sep 22, 2017
Maintains: Buy
Price Target: $23 → $33
Current: $1.61
Upside: +1,949.69%
Feb 1, 2017
Upgrades: Buy
Price Target: n/a
Current: $278.45
Upside: -